{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "P",
                    "position": "30"
                },
                "variant_string_id": "SNCA A30P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "α-Synuclein (αS) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three αS point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of αS is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Membrane - bound conformations of αS likely mediate the function of the protein, but may also play a role in the aggregation and toxicity of the protein.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the link between α - Synuclein, its mutations, and Parkinson's disease, as well as the role of its normal function in synaptic vesicle binding and potential role in aggregation and toxicity.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Pulsed dipolar ESR measurements of distances up to 8.7 nm were used to study the effects of the three known PD - linked mutations on the detergent - and membrane - bound conformations of αS, as well as factors that govern the transition of the protein between the extended helix and broken helix states.",
                    "judgment": "Yes",
                    "reasoning": "The ESR measurements are relevant to studying the conformation changes of αS which are related to the disease mechanism of Parkinson's disease as the conformation may be linked to its function and aggregation. ",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All measurements have been performed at 17.3 GHz and 60 K using a home - built Ku - band pulse FT - ESR/DQC spectrometer set to operate in 4 - pulse DEER mode. Controls and replicates details are not provided.",
                    "judgment": "No",
                    "reasoning": "There is no mention of basic controls (both normal/negative/wild type and abnormal/positive/null) and no statement about multiple replicates in the described ESR measurements.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The methods used for protein expression, purification, spin - labeling, and sample preparation for ESR measurements follow standard procedures described in the literature. However, there is no clear mention of the assay being broadly accepted, previously validated in other studies for this specific application, or being a commercial kit.",
                    "judgment": "No",
                    "reasoning": "Although some procedures follow literature methods, there is no clear evidence that the specific ESR assay instance for studying the A30P variant meets the criteria of being broadly accepted, previously validated, or a commercial kit with defined performance metrics.",
                    "next_step_or_outcome": "Do not use PS3/BS3"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "N/A"
            },
            "overall_conclusion": "The functional evidence for the SNCA A30P variant cannot be classified using PS3 or BS3 as the specific ESR assay instance does not meet the criteria for basic controls/replicates or accepted/validated assay requirements."
        },
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "E",
                    "alt": "K",
                    "position": "46"
                },
                "variant_string_id": "SNCA E46K"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "α - Synuclein (αS) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three αS point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of αS is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Membrane - bound conformations of αS likely mediate the function of the protein, but may also play a role in the aggregation and toxicity of the protein.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly defines the relationship between α - Synuclein, its mutations, and Parkinson's disease, along with its normal function and potential role in aggregation and toxicity.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Pulsed dipolar ESR measurements of distances up to 8.7 nm were used to study the effects of the three known PD - linked mutations on the detergent - and membrane - bound conformations of αS, as well as factors that govern the transition of the protein between the extended helix and broken helix states.",
                    "judgment": "Yes",
                    "reasoning": "The ESR measurements are relevant to understanding the conformation changes of αS which are associated with the disease mechanism of Parkinson's disease through the protein's function and aggregation.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All measurements have been performed at 17.3 GHz and 60 K using a home - built Ku - band pulse FT - ESR/DQC spectrometer set to operate in 4 - pulse DEER mode. Controls and replicates details are not provided.",
                    "judgment": "No",
                    "reasoning": "There is no information about basic controls (both normal/negative/wild type and abnormal/positive/null) and no statement about multiple replicates in the ESR measurements for the E46K variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The methods used for protein expression, purification, spin - labeling, and sample preparation for ESR measurements follow standard procedures described in the literature. However, there is no clear mention of the assay being broadly accepted, previously validated in other studies for this specific application, or being a commercial kit.",
                    "judgment": "No",
                    "reasoning": "Despite some procedures following literature methods, there is no clear evidence that the specific ESR assay instance for studying the E46K variant meets the criteria of being broadly accepted, previously validated, or a commercial kit with defined performance metrics.",
                    "next_step_or_outcome": "Do not use PS3/BS3"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "N/A"
            },
            "overall_conclusion": "The functional evidence for the SNCA E46K variant cannot be classified using PS3 or BS3 as the specific ESR assay instance does not meet the criteria for basic controls/replicates or accepted/validated assay requirements."
        },
        {
            "variant_id": {
                "Gene": "SNCA",
                "Protein_Change": {
                    "ref": "A",
                    "alt": "T",
                    "position": "53"
                },
                "variant_string_id": "SNCA A53T"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "α - Synuclein (αS) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three αS point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of αS is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Membrane - bound conformations of αS likely mediate the function of the protein, but may also play a role in the aggregation and toxicity of the protein.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly states the connection between α - Synuclein, its mutations, and Parkinson's disease, as well as its normal function and potential role in aggregation and toxicity.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "Pulsed dipolar ESR measurements of distances up to 8.7 nm were used to study the effects of the three known PD - linked mutations on the detergent - and membrane - bound conformations of αS, as well as factors that govern the transition of the protein between the extended helix and broken helix states.",
                    "judgment": "Yes",
                    "reasoning": "The ESR measurements are relevant to the disease mechanism as they help in understanding the conformation changes of αS which are related to its function and aggregation in Parkinson's disease.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "extracted_paper_info": "All measurements have been performed at 17.3 GHz and 60 K using a home - built Ku - band pulse FT - ESR/DQC spectrometer set to operate in 4 - pulse DEER mode. Controls and replicates details are not provided.",
                    "judgment": "No",
                    "reasoning": "There is no indication of basic controls (both normal/negative/wild type and abnormal/positive/null) and no statement about multiple replicates in the ESR measurements for the A53T variant.",
                    "next_step_or_outcome": "Proceed to Sub - step 3b"
                },
                {
                    "step_name": "Sub - step 3b: Accepted/Validated Assay (if basic controls/replicates were insufficient in 3a)",
                    "extracted_paper_info": "The methods used for protein expression, purification, spin - labeling, and sample preparation for ESR measurements follow standard procedures described in the literature. However, there is no clear mention of the assay being broadly accepted, previously validated in other studies for this specific application, or being a commercial kit.",
                    "judgment": "No",
                    "reasoning": "Although some procedures follow literature, there is no clear evidence that the specific ESR assay instance for studying the A53T variant meets the criteria of being broadly accepted, previously validated, or a commercial kit with defined performance metrics.",
                    "next_step_or_outcome": "Do not use PS3/BS3"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "N/A"
            },
            "overall_conclusion": "The functional evidence for the SNCA A53T variant cannot be classified using PS3 or BS3 as the specific ESR assay instance does not meet the criteria for basic controls/replicates or accepted/validated assay requirements."
        }
    ]
}